VERONA ROBERTS: Open Payments
NPI 1477986719 · BERWICK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,990 in 121 payments from 24 companies in 2025. Trend: 2023 $1,705 · 2024 $2,019 · 2025 $2,990
Food & beverage: $2,978Education: $12
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $674 |
| Novo Nordisk Inc | 17 | $444 |
| Otsuka America Pharmaceutical, Inc. | 15 | $233 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $227 |
| Phathom Pharmaceuticals, Inc. | 8 | $211 |
| Axsome Therapeutics, Inc. | 5 | $192 |
| MicroTransponder, Inc. | 1 | $178 |
| Vanda Pharmaceuticals Inc. | 5 | $109 |
| Verona Pharma, Inc. | 4 | $105 |
| ConvaTec Inc. | 4 | $94 |
Products named: WAINUA, REXULTI, Wegovy, CAPLYTA, VOQUEZNA, BREZTRI, Auvelity, Ozempic.
Industry payments across PA — which companies pay providers there.
